Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-022802
Filing Date
2020-02-19
Accepted
2020-02-19 16:06:17
Documents
60
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm205379-1_10k.htm 10-K 447318
2 EXHIBIT 4.1 tm205379d1_ex4-1.htm EX-4.1 11172
3 EXHIBIT 21.1 tm205379d1_ex21-1.htm EX-21.1 2458
4 EXHIBIT 23.1 tm205379d1_ex23-1.htm EX-23.1 3062
5 EXHIBIT 31.1 tm205379d1_ex31-1.htm EX-31.1 12826
6 EXHIBIT 31.2 tm205379d1_ex31-2.htm EX-31.2 13070
7 EXHIBIT 32.1 tm205379d1_ex32-1.htm EX-32.1 4998
8 EXHIBIT 32.2 tm205379d1_ex32-2.htm EX-32.2 5011
  Complete submission text file 0001104659-20-022802.txt   2716545

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT enzn-20191231.xml EX-101.INS 558426
10 XBRL TAXONOMY EXTENSION SCHEMA enzn-20191231.xsd EX-101.SCH 30353
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20191231_cal.xml EX-101.CAL 27377
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20191231_def.xml EX-101.DEF 56582
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20191231_lab.xml EX-101.LAB 203652
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20191231_pre.xml EX-101.PRE 168005
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36435 | Film No.: 20629673
SIC: 2836 Biological Products, (No Diagnostic Substances)